Gian Life Care Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Gian Life Care Ltd. on BSE

Load latest

Gian Life Care Ltd.

25 Jan 2022

15.99

2.37%

Company Update

Gian Life Care Ltd - 542918 - Sub: Intimation Under Regulation 30 Of The Securities And …

BSE India

Dear Sir/Madam, In compliance with Regulation 30 read with Schedule III, we wish to intimate that the Board of Directors of Gian Life Care Limited ('the Company') at its Meeting held on Tuesday, January 25, 2022, have inter-alia considered and approved proposal to enter into Management & Operations Services Agreement with M/s. Health Well Diagnostics Private Limited. Details with respect to the said purchase as required under Regulation 30 read with Schedule III of the Listing Regulations and the SEBI Circular CIR/CFD/CMD/4/2015 dated 9 September 2015 are attached as Annexure A to this letter. Kindly take the above on record and acknowledge receipt of the same. Thanking You, Yours faithfully, For GIAN LIFE CARE LIMITED

pdf

Gian Life Care Ltd.

25 Jan 2022

15.99

2.37%

Company Update

Gian Life Care Ltd - 542918 - Announcement under Regulation 30 (LODR)-Change in RTA

BSE India

Dear Sir/Madam, In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular CIR/CFD/CMD/4/2015 dated 9 September 2015, we wish to intimate that the Board of Directors of Gian Life Care Limited ('the Company') at its Meeting held on Tuesday, January 25, 2022, have inter-alia decided and approved change in Registrar and Share Transfer Agent of the Company from M/s. Cameo Corporate Services Private Limited to M/s. Skyline Financial Services Private Limited, as a measure to reduce cost of service which shall be effective from the date of entering into tripartite agreement as referred to in Regulation 7(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, of which, a separate announcement shall be made to the Exchange. Kindly take the above on record and acknowledge receipt of the same.

pdf

Gian Life Care Ltd.

20 Jan 2022

15.99

2.37%

Company Update

Gian Life Care Ltd - 542918 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Scrip Code:- 542918 Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 Dear Sir/Madam, We enclose herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for period ended December 31, 2021 for your information and record. Thanking You, Yours faithfully, For GIAN LIFE CARE LIMITED

pdf

Gian Life Care Ltd.

20 Jan 2022

15.99

2.37%

Company Update

Gian Life Care Ltd - 542918 - Statement Of Investor Complaints For The Quarter Ended December 2021

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Arun Kumar GuptaDesignation :- Managing Director / Whole Time Director

Gian Life Care Ltd.

15 Jan 2022

15.99

2.37%

Company Update

Gian Life Care Ltd - 542918 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI …

BSE India

Dear Sir/Madam, Sub: Disclosure under Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended ('SEBI Insider Trading Regulations') - Continual Disclosure Pursuant to Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, please find attached herewith disclosure dated January 14, 2022, in Form 'C' as received from Shri Arun Kumar Gupta, Promoter of the Company. Kindly take the same on record. Yours faithfully, For GIAN LIFE CARE LIMITED

pdf

Gian Life Care Ltd.

08 Jan 2022

15.99

2.37%

Company Update

Gian Life Care Ltd - 542918 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI …

BSE India

Sub: Disclosure under Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended ('SEBI Insider Trading Regulations') - Continual Disclosure Pursuant to Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, please find attached herewith disclosure dated January 07, 2022, in Form 'C' as received from Shri Arun Kumar Gupta, Promoter of the Company. Kindly take the same on record. Yours faithfully, For GIAN LIFE CARE LIMITED (Vanshul Asnani) Company Secretary & Compliance Officer

pdf

Gian Life Care Ltd.

30 Dec 2021

15.99

2.37%

Company Update

Gian Life Care Ltd - 542918 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

BSE India

Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/ CFD/ CMD1/114/2019 dated October 18, 2019, we would like to inform you that the Board of Directors of Gian Life Care Limited ('the Company') at its Meeting held on Wednesday, December 29, 2021, took note, considered and approved Appointment of M/s. Sharp Aarth & Co., Chartered Accountants, (Firm Reg. No. 132748W) as Statutory Auditors to fill up the Casual Vacancy in the office of the Statutory Auditors subject to the approval of the members of the Company to hold office from the date of appointment till the conclusion of the Annual General Meeting of the Company to be held in the year 2022. M/s. Sharp Aarth & Co., Chartered Accountants hold a valid certificate issued by the Peer Review Board of the Institute of Chartered Accountants of India. Kindly take the above on record and acknowledge receipt of the same.

pdf

Gian Life Care Ltd.

22 Dec 2021

15.99

2.37%

Company Update

Gian Life Care Ltd - 542918 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Sub: Intimation cum update under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding incorporation/ formation of Wholly Owned Subsidiary Company Dear Sir/Madam, This is further to our intimation dated December 07, 2021, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular CIR/CFD/CMD/4/2015 dated 9 September 2015, regarding incorporation of Wholly Owned Subsidiary of the Company Further to the above intimation, the said Wholly Owned Subsidiary of the Company in the name and style of 'M/s. Gian Path Lab (India) Private Limited' has been incorporated today i.e. December 22, 2021 bearing CIN:- U85100UP2021PTC157224. Details as required under Regulation 30 and the SEBI Circular CIR/CFD/CMD/4/2015 dated 9 September 2015 are attached as Annexure A to this letter.

pdf

Gian Life Care Ltd.

17 Dec 2021, 03:50PM

15.99

2.37%

Company Update

Gian Life Care Ltd - 542918 - Announcement Under Regulation 30 Of The SEBI (Listing Obligation …

BSE India

In compliance with Regulation 30 read with Schedule III, Part A of the Listing Regulations, we would like to inform you that the Board of Directors of Gian Life Care Limited ('the Company') at its Meeting held on Thursday, December 16, 2021, have inter-alia approved signing and execution of LLP agreement of M/s. Gian Satguru Pathology LLP. Details as required under Regulation 30 read with Schedule III Part A of the Listing Regulations and the SEBI Circular CIR/CFD/CMD/4/2015 dated 9 September 2015 are attached as Annexure A to this letter

pdf

Gian Life Care Ltd.

07 Dec 2021

15.99

2.37%

Company Update

Gian Life Care Ltd - 542918 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we would like to inform that the Board of Directors at their meeting held on Monday, December 06, 2021, has approved incorporation/ formation of Wholly Owned Subsidiary Company to undertake the business of acquiring and running pathological labs and laboratories across the Country. The said proposal is expected to help the Company in covering new areas across all States and in turn would strengthen the financial position of the Parent Company. Details as required under Regulation 30 read with Schedule III of the Listing Regulations and the SEBI Circular CIR/CFD/CMD/4/2015 dated 9 September 2015 are attached as Annexure A to this letter. Kindly take the above on record and acknowledge receipt of the same. Thanking You, Yours faithfully, For GIAN LIFE CARE LIMITED

pdf

VOTE: Is Gian Life Care Ltd. worth buying?

16 Votes:

Buy 62.5%

Sell 6.25%

Hold 31.25%